Cargando…

Current and future G protein-coupled receptor signaling targets for heart failure therapy

Although there have been significant advances in the therapy of heart failure in recent decades, such as the introduction of β-blockers and antagonists of the renin–angiotensin–aldosterone system, this devastating disease still carries tremendous morbidity and mortality in the western world. G prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siryk-Bathgate, Ashley, Dabul, Samalia, Lymperopoulos, Anastasios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797606/ https://www.ncbi.nlm.nih.gov/pubmed/24143078 http://dx.doi.org/10.2147/DDDT.S35905

Ejemplares similares

Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison
por: Dabul, Samalia, et al.
Publicado: (2015)

βArrestins in Cardiac G Protein-Coupled Receptor Signaling and Function: Partners in Crime or “Good Cop, Bad Cop”?
por: Lymperopoulos, Anastasios, et al.
Publicado: (2013)

Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease
por: Parker, Barbara M., et al.
Publicado: (2018)

Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy
por: Lymperopoulos, Anastasios, et al.
Publicado: (2017)

GRK2 blockade with βARKct is essential for cardiac β(2)-adrenergic receptor signaling towards increased contractility
por: Salazar, Norma C, et al.
Publicado: (2013)

Cardiac RGS Proteins in Human Heart Failure and Atrial Fibrillation: Focus on RGS4
por: Borges, Jordana I., et al.
Publicado: (2023)

The place of ARBs in heart failure therapy: is aldosterone suppression the key?
por: Markan, Uma, et al.
Publicado: (2019)

Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4
por: Praveen, Praveen, et al.
Publicado: (2019)

Characterisation of a cell-free synthesised G-protein coupled receptor
por: Shilling, Patrick J., et al.
Publicado: (2017)

Regulator of G-Protein Signaling-4 Attenuates Cardiac Adverse Remodeling and Neuronal Norepinephrine Release-Promoting Free Fatty Acid Receptor FFAR3 Signaling
por: Carbone, Alexandra M., et al.
Publicado: (2022)

Chronic Activation of the G Protein-Coupled Receptor 30 with Agonist G-1 Attenuates Heart Failure
por: Kang, Shoulei, et al.
Publicado: (2012)

The current and future burden of heart failure in Portugal
por: Gouveia, Miguel, et al.
Publicado: (2019)

Current and future use of neuromodulation in heart failure( )
por: Duncker, David, et al.
Publicado: (2022)

Autonomic Nervous System Regulation of Epicardial Adipose Tissue: Potential Roles for Regulator of G Protein Signaling-4
por: Carbone, Alexandra M., et al.
Publicado: (2022)

Targeting heart failure with preserved ejection fraction: current status and future prospects
por: Kanwar, Manreet, et al.
Publicado: (2016)

Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function
por: Guitart-Mampel, Mariona, et al.
Publicado: (2021)

Short-Chain Fatty Acid Receptors and Cardiovascular Function
por: Lymperopoulos, Anastasios, et al.
Publicado: (2022)

Pediatric Heart Failure: Current State and Future Possibilities
por: Rossano, Joseph W., et al.
Publicado: (2015)

The therapeutic potential of targeting cardiac RGS4
por: Del Calvo, Giselle, et al.
Publicado: (2023)

Impaired desensitization of a human polymorphic α(2B)-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells
por: Nguyen, Kristy, et al.
Publicado: (2011)

Physiology and pharmacology of the cardiovascular adrenergic system
por: Lymperopoulos, Anastasios
Publicado: (2013)

Editorial to the IJMS Special Issue on Sglt2 Inhibitors Vol. 1
por: Lymperopoulos, Anastasios
Publicado: (2023)

Hemorphins Targeting G Protein-Coupled Receptors
por: Ayoub, Mohammed Akli, et al.
Publicado: (2021)

Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor
por: Gulati, Sahil, et al.
Publicado: (2018)

Epigenetic Therapies for Heart Failure: Current Insights and Future Potential
por: Napoli, Claudio, et al.
Publicado: (2021)

Selenium, Selenoproteins, and Heart Failure: Current Knowledge and Future Perspective
por: Al-Mubarak, Ali A., et al.
Publicado: (2021)

Adrenal βarrestin1 targeting for tobacco–associated cardiac dysfunction treatment: Aldosterone production as the mechanistic link
por: Solesio, Maria E, et al.
Publicado: (2019)

G-Protein Coupled Receptor Signaling and Mammalian Target of Rapamycin Complex 1 Regulation
por: Melick, Chase H., et al.
Publicado: (2022)

A Bright and Colorful Future for G-Protein Coupled Receptor Sensors
por: Ravotto, Luca, et al.
Publicado: (2020)

G Protein-Coupled Receptors: Structure, Signaling, and Physiology
por: Teixeira, Alexandra
Publicado: (2011)

High capacity in G protein-coupled receptor signaling
por: Keshelava, Amiran, et al.
Publicado: (2018)

Allosteric modulation of G protein-coupled receptor signaling
por: Shen, Siyuan, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction: current status and challenges for the future
por: van der Velden, J., et al.
Publicado: (2016)

Heart Failure in the Middle East Arab Countries: Current and Future Perspectives
por: Elasfar, Abdelfatah A., et al.
Publicado: (2020)

Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions
por: Javaheri, Shahrokh, et al.
Publicado: (2022)

Current status of outpatient heart failure management in Egypt and recommendations for the future
por: Hassanein, Mahmoud, et al.
Publicado: (2023)

Application of Nanoparticles for Targeting G Protein-Coupled Receptors
por: Ma, Xin, et al.
Publicado: (2018)

Targeting G protein-coupled receptor for pain management
por: Li, Hongyan, et al.
Publicado: (2017)

Current and emerging drug targets in heart failure treatment
por: Ghionzoli, Nicolò, et al.
Publicado: (2021)

Osteopontin and LDLR Are Upregulated in Hearts of Sudden Cardiac Death Victims With Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
por: Patel, Mausam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_njpbm0jvbi4b65lsborr9n3t0l